The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma

15Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Locally advanced sarcomas in the extremity and in the retroperitoneum/abdominal cavity (peritoneal sarcomatosis, PS) can be managed administering chemotherapy locally using isolated limb perfusion (ILP) and hyperthermic intraperitoneal chemotherapy (HIPEC), respectively. In this review, the authors discuss the pros and cons of the use of these locoregional therapies in locally advanced soft tissue sarcoma, with a view to establishing their role in the multidisciplinary approach to these difficult diseases. J. Surg. Oncol. 2015 111:570-579.

Cite

CITATION STYLE

APA

Colombo, C., Baratti, D., Kusamura, S., Deraco, M., & Gronchi, A. (2015, April 1). The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma. Journal of Surgical Oncology. John Wiley and Sons Inc. https://doi.org/10.1002/jso.23808

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free